SYK and leukemia: A new spleen tyrosine kinase (SYK) P-site inhibitor, 1,4-Bis (9-O dihydroquinidinyl) phthalazine/hydroquinidine 1,4-phathalazinediyl diether (C-61), significantly increased H2O2-caused programmed cell death of primary leukemia cells from each of five relapsed B-lineage acute lymphoblastic leukemia (ALL) subjects [143].